Variant report
Variant | nsv823041 |
---|---|
Chromosome Location | chr5:27176399-27191305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:27188701..27190583-chr5:27195878..27197425,2 | K562 | blood: | |
2 | chr5:27187232..27190139-chr5:27197303..27199539,2 | MCF-7 | breast: | |
3 | chr5:27177888..27180469-chr5:27180601..27183505,3 | MCF-7 | breast: | |
4 | chr5:27178494..27180623-chr5:27183563..27186958,3 | MCF-7 | breast: | |
5 | chr5:27178494..27180623-chr5:27183563..27186958,3 | MCF-7 | breast: | |
6 | chr5:27177888..27180469-chr5:27180601..27183505,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181129837 | chr5:27180281-27180282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115500745 | chr5:27180347-27180348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199968817 | chr5:27180374-27180375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72010463 | chr5:27180375-27180376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530325093 | chr5:27180433-27180434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553030434 | chr5:27180479-27180480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574505445 | chr5:27180500-27180501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77746919 | chr5:27180588-27180589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185668354 | chr5:27180591-27180592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575347668 | chr5:27180592-27180593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117895776 | chr5:27180597-27180598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74991881 | chr5:27180659-27180660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190432999 | chr5:27180703-27180704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557145874 | chr5:27180717-27180718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143884701 | chr5:27180718-27180719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557847929 | chr5:27180722-27180723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541396563 | chr5:27180735-27180736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201491326 | chr5:27180736-27180737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559295478 | chr5:27180737-27180738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs80060394 | chr5:27180762-27180763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113832813 | chr5:27180874-27180875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563108601 | chr5:27180920-27180921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569818244 | chr5:27180936-27180937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs180783569 | chr5:27180946-27180947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552531305 | chr5:27180983-27180984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368675573 | chr5:27181014-27181015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117783261 | chr5:27181018-27181019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114507877 | chr5:27181021-27181022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568016524 | chr5:27181066-27181067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371264573 | chr5:27181078-27181079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375026638 | chr5:27181092-27181093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs151142556 | chr5:27181155-27181156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575289738 | chr5:27181192-27181193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72740668 | chr5:27181251-27181252 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs185447566 | chr5:27181321-27181322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573017884 | chr5:27181402-27181403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376148285 | chr5:27181460-27181461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113659137 | chr5:27181488-27181489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561657937 | chr5:27181490-27181491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113292134 | chr5:27181510-27181511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369496491 | chr5:27181585-27181586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs80219937 | chr5:27181595-27181596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541861317 | chr5:27181616-27181617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114133254 | chr5:27181647-27181648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530935241 | chr5:27181650-27181651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543315947 | chr5:27181655-27181656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552660650 | chr5:27181677-27181678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201352022 | chr5:27181707-27181708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562894843 | chr5:27181710-27181711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564486328 | chr5:27181714-27181715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27180200-27181400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr5:27180400-27181400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr5:27181400-27186800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:27185000-27185400 | Enhancers | Fetal Brain Male | brain |
5 | chr5:27185400-27186600 | Weak transcription | Fetal Brain Male | brain |
6 | chr5:27186600-27187000 | Enhancers | Fetal Brain Male | brain |
7 | chr5:27186800-27187200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |